| Charlson Comorbidity Index: ICD-9 Update and ICD-10 Translation |
9 |
| The Challenge of Managing Atopic Dermatitis in the United States |
7 |
| Comparing Treatment Modalities for End-Stage Renal Disease: A Meta-Analysis |
6 |
| Temporal Trends in Survival and Healthcare Costs in Patients with Multiple Myeloma in the United States |
6 |
| Estimating the Real World Cost of Diabetes Mellitus in the United States During an 8-Year Period Using 2 Cost Methodologies |
6 |
| Group-Based Trajectory Models to Identify Sociodemographic and Clinical Predictors of Adherence Patterns to Statin Therapy Among Older Adults |
5 |
| Standardized Review and Approval Process for High-Cost Medication Use Promotes Value-Based Care in a Large Academic Medical System |
4 |
| Real-World Treatment Patterns in Patients with Castrate-Resistant Prostate Cancer and Bone Metastases |
4 |
| Treatment Persistence and Healthcare Costs Among Patients with Rheumatoid Arthritis After a Change in Targeted Therapy |
4 |
| Patient Preferences Associated with Therapies for Psoriatic Arthritis: A Conjoint Analysis |
4 |
| Predictors of Transitioning to Incident Chronic Opioid Therapy Among Working-Age Adults in the United States |
4 |
| Computed Tomography Colonography Less Costly Than Colonoscopy for Colorectal Cancer Screening of Commercially Insured Patients |
4 |
| Economic Burden of Adverse Events Associated with Immunotherapy and Targeted Therapy for Metastatic Melanoma in the Elderly |
3 |
| Alternative Payment Models in Medica Oncology: Assessing Quality-of-Care Outcomes Under Partial Capitation |
3 |
| The Economic Value of Customized versus Off-the-Shelf Knee Implants in Medicare Fee-for-Service Beneficiaries |
3 |
| Tumor Necrosis Factor Inhibitor Therapy and the Risk for Depression Among Working-Age Adults with Rheumatoid Arthritis |
3 |
| Delayed Treatment Acceleration in Patients with Rheumatoid Arthritis Who Have Inadequate Response to Initial Tumor Necrosis Factor Inhibitors: Data from the Corrona Registry |
2 |
| Treatment Patterns and Costs of Chronic Inflammatory Demyelinating Polyneuropathy: A Claims Database Analysis |
2 |
| Implementation of a Pharmacist-Led Diabetes Management Protocol |
2 |
| Costs and Healthcare Resource Utilization Associated with Hospital Admissions of Patients with Metastatic or Nonmetastatic Prostate Cancer |
2 |
| Outcomes Based Contracting for Disease-Modifying Therapies in Multiple Sclerosis: Necessary Conditions for Paradigm Adoption |
2 |
| Real World Dose Modification Patterns of Subcutaneous Tocilizumab Among Patients with Rheumatoid Arthritis |
2 |
| Potential Cost-Savings with Once-Daily Aminomethylcycline Antibiotic versus Vancomycin in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections |
2 |
| Evolution of the Medicare Part D Medication Therapy Management Program from Inception in 2006 to the Present |
2 |
| Clinical and Budget Impact of Increasing Colorectal Cancer Screening by Blood- and Stool-Based Testing |
2 |
| Budget Impact Analysis of Using Daunorubicin-Cytarabine Liposome in Patients with Newly Diagnosed Therapy-Related AML or AML and Myelodysplasia Related Changes |
1 |
| A Proposed Intervention to Decrease Resident-Performed Cataract Surgery Cancellation in a Tertiary Eye Care Center |
1 |
| Differences in Patient Demographics and Healthcare Costs of Patients with PIDD Receiving Intravenous or Subcutaneous Immunoglobulin Therapies in the United States |
1 |
| Cost Saving Opportunities with an Oral and Intravenous Once-Daily Aminomethylcycline Antibiotic for Hospitalized Patients with Community - Acquired Bacterial Pneumonia: Findings from Decision-Analytic Models |
1 |
| Prevalence and Economic Burden of Epilepsy in the Institutionalized Medicare Fee-for-Service Population |
1 |
| Newly Diagnosed Hepatitis C in the US Commercially Insured Population Before and After the 2012 Implementation of Expanded Screening Guidelines |
1 |
| Comparing the Medicaid Prospective Drug Utilization Review Program Cost-Savings Methods Used by State Agencies in 2015 and 2016 |
1 |
| US Healthcare Trends and Contradictions in 2019 |
1 |
| Trends in Utilization, Spending, and Prices of Smoking-Cessation Medications in Medicaid Programs: 25 Years Empirical Data Analysis, 1991-2015 |
1 |
| Prior Authorization for Elective Diagnostic Catheterization: The Value of Reviewers in Cases with Clinical Ambiguity |
1 |
| Long-Term Outcomes of a Cardiovascular and Diabetes Risk-Reduction Program Initiated by a Self-Insured Employer |
1 |
| The Prevalence and Payer Costs of Potentially Avoidable Emergent Care Visits for Suspected Amniotic Membrane Rupture in Pregnant Women |
1 |
| Budget Impact of Adding Vedolizumab to a Health Plan Formulary as Another First-Line Biologic Option for Ulcerative Colitis and Crohn's Disease |
1 |
| Assessing the Level of Patient-Specific Treatment Recommendations in Clinical Practice Guidelines for Hemodialysis Vascular Access in the United States |
0 |
| Influencing Patient Outcomes Through Enhanced Multidisease-Focused Interventions |
0 |
| Standardized Documentation Can Improve Diagnostic Testing Decisions for Patients with Cardiovascular Disease |
0 |
| Can Academic Detailing Move the Needle for Patients with Diabetes in a State-Based Prescription Drug Benefit Program? |
0 |
| Analysis of Real World Dosing Patterns for the 3 FDA-Approved Medications in the Treatment of Fibromyalgia |
0 |
| The Challenge of Variable Costs in Decisions Based on Cost-Effectiveness Evidence: A Case Study for Brodalumab |
0 |
| A Shift in Party Majority, a Shift in Priority? What the Pharmaceutical Industry Can Expect |
0 |
| Healthcare Costs and Absenteeism Among Caregivers of Adults with Partial-Onset Seizures: Analysis of Claims from an Employer Database |
0 |
| Patient Preferences and Therapeutic Satisfaction with Topical Agents for Rosacea: A Survey-Based Study |
0 |
| Effects of Educational Messaging on Urgent and Emergent Care-Seeking Behaviors Among Publicly Insured Populations |
0 |
| Changes in Medical Services and Drug Utilization and Associated Costs After Narcolepsy Diagnosis in the United States |
0 |
| Dipeptidyl Peptidase-4 Inhibitors and Joint Pain: A Retrospective Cohort Study of Older Veterans with Type 2 Diabetes Mellitus |
0 |
